logo
Select company
Select metric
23.5%Stock Based Compensation Margin
VS
Market
11
Sector
35
Industry
63
History
66
$ 11.73Close
$ 5.31 - $ 12.34 52-Week Range
Ticker Information

Ticker

RGNX

Company Name

REGENXBIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

REGENXBIO INC - Stock Based Compensation Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

RGNX - SB Comp % Historical data
DateRevenuesStock Based CompensationStock Based Compensation Margin
6/30/2025$ 155.78M$ 36.62M23.5%
3/31/2025$ 156.72M$ 37.4M23.86%
12/31/2024$ 83.33M$ 38.46M46.16%
9/30/2024$ 84.33M$ 37.26M44.18%
6/30/2024$ 89.04M$ 37.59M42.22%
3/31/2024$ 86.73M$ 38.66M44.58%
12/31/2023$ 90.24M$ 40.27M44.62%
9/30/2023$ 99.37M$ 41.34M41.6%
6/30/2023$ 96.97M$ 41.36M42.65%
3/31/2023$ 109.64M$ 41.19M37.57%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • REGENXBIO INC's latest trailing twelve months (TTM) SB Comp % stands at 21.56%.
  • Over the past 5 years, REGENXBIO INC's average SB Comp % has been 29.32%.
  • The median SB Comp % for REGENXBIO INC during this period was 30.02%
  • REGENXBIO INC reached its highest SB Comp % over the past 5 years at 46.16%.
  • The lowest SB Comp % recorded by REGENXBIO INC in the same timeframe 8.25%

REGENXBIO INC's SB Comp % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

SB Comp % Benchmarks
CompanySB Comp %
CTMX : CYTOMX THERAPEUTICS INC 5.19%XNCR : XENCOR INC 32.41%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC 25.66%YMAB : Y-MABS THERAPEUTICS INC 15.83%GLUE : MONTE ROSA THERAPEUTICS INC 10.64%HRTX : HERON THERAPEUTICS INC 6.9%NKTR : NEKTAR THERAPEUTICS 23.46%PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC 35.48%LXRX : LEXICON PHARMACEUTICALS INC 18.1%VNDA : VANDA PHARMACEUTICALS INC 5.38%

Definition of Stock Based Compensation Margin

[Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
SB Comp. / Revenues
(=) SB Comp %
SB Comp % for REGENXBIO INC is calculated as follows: SB Comp. [ $ 31.24M ] / Revenues [ $ 144.89M ]
(=) SB Comp % [ 21.56% ]

RGNX - Stock Based Compensation Margin, Last 5 years

8.25%

Minimum

Dec 31, 2021

46.16%

Maximum

Dec 31, 2024

29.32%

Average

30.02%

Median

SB Comp % Benchmark Analysis

The chart above depicts the distribution of SB Comp % for companies in the Total Stock Market. The average SB Comp % of the companies is 1.72% with a standard deviation of 1.9%.
The following table provides additional summary stats:
SB Comp % in the Market:
filtered constituents2.99K
min-3.97%
max8.43%
average1.72%
median1.04%
std1.9%